Bausch & Lomb's three-year strategic plan targets $50 mil. in expense reductions.
This article was originally published in The Tan Sheet
Executive Summary
BAUSCH & LOMB AIMING FOR $50 MIL. REDUCTION IN EXPENSES under a three-year strategic plan presented by company execs in a Dec. 6 meeting with institutional investors in New York. The cost-cutting plan consists of reductions in "back-office and non-commercial costs," the company said, including a freeze on salary increases for senior executives of the company. The plan will not lead to any change in advertising, marketing, R&D, or current investment programs.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning